Galantamine is beneficial in both patients with vascular dementia and patients with Alzheimer's disease with cerebrovascular disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1409, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Galantamine shows sustained cognitive benefits in patients with Alzheimer's disease (AD)

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Effects of Statins on Cognitive Function in Patients with Alzheimer's Disease in Galantamine Clinical Trials

By Winblad Bengt  

Drugs & Aging, Vol. 24, Iss. 1, 2007-01 ,pp. : 57-61

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Apolipoprotein E Gene Variants of Alzheimer's Disease and Vascular Dementia Patients in a Community Population of Nanking

By  

Medicinal Chemistry, Vol. 10, Iss. 8, 2014-01 ,pp. : 783-788

Bentham Science Publishers

Access to resources Recommend Favorite